Vale S.A. VALE3.SA SAO · Basic materials · Brazil
R$ 58.70 -0.51% -R$ 0.30
Summary
55 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 8.9 USD is left as free cash.
What to watch
- Earnings per share fell by 47% a year over the last 3 years.
- It pays out more in dividends than it earns: 547% of profit.
- It missed profit estimates 6 times in the last 8 quarters.
- Out of every 100 USD of revenue, only 1.7 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 57.2 USD for 1 USD of yearly profit. Over the last five years it was 8.9 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 0.3% a year over 5 years. Over the last 3 years it fell by 3.9% a year. For the next fiscal year analysts expect revenue to grow by 8.9%. Earnings per share fell by 47% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 69 USD
- Research and development 2.2 USD
- Sales and administration 4.9 USD
- Taxes and other 22 USD
- Net profit 1.7 USD
Net profit, industry median (Industrial Materials) 11 USD
Out of every 100 USD of revenue, 1.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 9.56%
- Paid out of profit
- 547%
You receive R$ 5.61 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 17
- Hold 11
- Sell 3
No analyst has published a price target.
55% of the analysts recommend buying.
Analysts in detail